rs12983047

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000598758.5(TGFB1):​n.302+3534T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.196 in 151,846 control chromosomes in the GnomAD database, including 3,263 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3263 hom., cov: 31)

Consequence

TGFB1
ENST00000598758.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.773

Publications

16 publications found
Variant links:
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
  • Camurati-Engelmann disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • inflammatory bowel disease, immunodeficiency, and encephalopathy
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.332 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFB1ENST00000598758.5 linkn.302+3534T>C intron_variant Intron 2 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.196
AC:
29775
AN:
151728
Hom.:
3249
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.265
Gnomad AMI
AF:
0.401
Gnomad AMR
AF:
0.166
Gnomad ASJ
AF:
0.167
Gnomad EAS
AF:
0.346
Gnomad SAS
AF:
0.189
Gnomad FIN
AF:
0.145
Gnomad MID
AF:
0.184
Gnomad NFE
AF:
0.158
Gnomad OTH
AF:
0.188
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.196
AC:
29811
AN:
151846
Hom.:
3263
Cov.:
31
AF XY:
0.195
AC XY:
14498
AN XY:
74200
show subpopulations
African (AFR)
AF:
0.265
AC:
10972
AN:
41344
American (AMR)
AF:
0.165
AC:
2521
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.167
AC:
580
AN:
3470
East Asian (EAS)
AF:
0.345
AC:
1781
AN:
5156
South Asian (SAS)
AF:
0.189
AC:
909
AN:
4812
European-Finnish (FIN)
AF:
0.145
AC:
1529
AN:
10550
Middle Eastern (MID)
AF:
0.170
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
0.158
AC:
10712
AN:
67942
Other (OTH)
AF:
0.186
AC:
391
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1171
2342
3513
4684
5855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.165
Hom.:
996
Bravo
AF:
0.204
Asia WGS
AF:
0.294
AC:
1022
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
12
DANN
Benign
0.75
PhyloP100
0.77
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12983047; hg19: chr19-41834499; API